Back to companies

Revolution Medicines Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Revolution Medicines Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Revolution Medicines Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Mark A. Goldsmith, M.D., Ph.D.

Chief Executive Officer; Chairman; President Executive Board Since: 2020 Age: 63

Jack Anders

Chief Financial Officer Senior Management Since: 2022 Age: 48

Margaret Horn

Chief Operating Officer Senior Management Since: 2018 Age: 62

Wei Lin, M.D.

Chief Medical Officer Senior Management Since: 2023 Age: 56

Jan Smith, Ph.D.

Chief Scientific Officer Senior Management
Gain a 360-degree view of Revolution Medicines Inc and make more informed decisions for your business Gain a 360-degree view of Revolution Medicines Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer